Washington, DC - "Since 2012 when the FDA first approved Truvada for a pre-exposure prophylaxis (PrEP) indication, there has been a safe and effective HIV prevention method that, when used along with safer sex practices, can help lower the chances of getting sexually-transmitted HIV,” said Debra Birnkrant, M.D., director of FDA’s Division of Antiviral Products. “We have also reinforced to health care professionals and at-risk individuals that before starting PrEP with Truvada, or emtricitabine/tenofovir disoproxil fumarate, and during its use, health care professionals should routinely screen patients for HIV, at least once every three months.

Washington, DC -  Diverse perspectives are essential to advancing science, especially in the global health arena where regional, gender and cultural experiences can be quite different. I applaud NIH Director Dr. Francis S. Collins on his recent announcement that he is committed to inclusiveness and believes it is time to end the tradition of all-male speaking panels at scientific meetings. I and the Fogarty International Center staff enthusiastically join him in this effort.

Washington, DC - The U.S. Food and Drug Administration today released a proposed draft guidance, “Reducing Microbial Food Safety Hazards in the Production of Seed for Sprouting,” intended to make the sprout seed industry (seed growers, conditioners, packers, holders, suppliers, and distributors) aware of the agency’s serious concerns with the continuing outbreaks of foodborne illness associated with the consumption of raw and lightly-cooked sprouts.

Dallas, Texas - Veterans who have post-traumatic stress disorder (PTSD) and/or depression were more likely to use cardiac rehabilitation services after an episode of ischemic heart disease than those who didn’t have PTSD or depression, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Dallas, Texas - A large study of Swedish men found that those who were even mildly overweight around age 18 were more likely develop cardiomyopathy in adulthood — an uncommon heart muscle condition that can cause heart failure, according to new research in the American Heart Association’s journal Circulation.

Washington, DC - Researchers at the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, have developed a novel technique that prevents the obstruction of blood flow, a common fatal complication of transcatheter mitral valve replacement (TMVR). The new method, called LAMPOON, may increase treatment options for high-risk patients previously ineligible for heart valve procedures. The Journal of the American College of Cardiology (link is external) published the findings online on May 20.